Description

Hydroxyethyl -Cyclodextrin

Hydroxyethyl -Cyclodextrin is a hydroxyalkylated derivative of -Cyclodextrin used in pharmaceutical research, formulation development, analytical studies, biotechnology, nutraceutical, cosmetic, and specialty applications where improved aqueous compatibility, inclusion complex formation, solubilization, and stabilization are important. Hydroxyethyl substitution modifies the exterior hydroxyl groups of the parent b-Cyclodextrin structure while preserving the internal cavity responsible for host-guest interactions.
• Hydroxyethyl-substituted derivative of -Cyclodextrin
• Based on a seven-Glucose-unit cyclic oligosaccharide structure
• Improved aqueous compatibility compared with unmodified b-Cyclodextrin
• Suitable for inclusion-complex, solubilization, stabilization, and formulation research
• Functional behavior depends on degree of substitution, substitution distribution, purity, and formulation conditions
• Supported by technical documentation for supplier qualification and material characterization
Hydroxyethyl -Cyclodextrin belongs to the broader family of chemically modified Cyclodextrins developed to alter the physicochemical behavior of natural Cyclodextrins. The parent -Cyclodextrin contains seven glucose units connected through α-(1→4) glycosidic bonds, forming a ring-shaped molecule with a hydrophilic exterior and a relatively hydrophobic internal cavity. Introduction of hydroxyethyl groups increases the hydrophilic character of the molecule and can improve aqueous solubility and formulation flexibility.
The degree of hydroxyethyl substitution is an important characteristic of Hydroxyethyl -Cyclodextrin. Hydroxyethyl groups may be distributed across multiple hydroxyl positions, and commercial grades may vary in average substitution level. These differences can influence water solubility, molecular weight, viscosity, aggregation behavior, guest-molecule affinity, and inclusion-complex stability. For this reason, degree of substitution and related compositional characteristics should be considered during product qualification.
In pharmaceutical development, Hydroxyethyl -Cyclodextrin may be evaluated as a solubilizing and complexing excipient for active compounds with limited aqueous solubility. Its internal cavity can associate noncovalently with appropriately sized hydrophobic molecules or molecular regions, while its modified exterior supports compatibility with aqueous systems. Published formulation research has demonstrated its ability to form inclusion complexes and improve the apparent solubility or dissolution behavior of selected poorly soluble compounds.
Hydroxyethyl -Cyclodextrin may also be considered in oral, topical, liquid, solid, and experimental drug-delivery systems depending on the grade, target molecule, and regulatory requirements. Complexation efficiency should be evaluated experimentally because molecular size, shape, ionization state, formulation pH, temperature, solvent composition, Cyclodextrin concentration, and competing formulation ingredients can all affect host-guest interaction.
Beyond pharmaceutical development, Hydroxyethyl -Cyclodextrin may be evaluated in nutraceutical, cosmetic, analytical, and specialty formulation programs. Potential functions include stabilization of hydrophobic compounds, reduction of volatility, improvement of aqueous dispersion, odor or taste modification, and controlled presentation of functional ingredients. It may also be used in host-guest chemistry, molecular recognition, supramolecular research, and analytical studies.
For companies looking to buy Hydroxyethyl -Cyclodextrin, supplier qualification should extend beyond confirmation of the parent Cyclodextrin identity. A qualified Hydroxyethyl -Cyclodextrin supplier should provide information regarding average degree of substitution, substitution distribution where available, assay or purity, residual unmodified -Cyclodextrin, related Cyclodextrin derivatives, water content, residual solvents, elemental impurities, appearance, solution properties, and recommended storage conditions.
CarboMer approaches Hydroxyethyl -Cyclodextrin sourcing with a regulation-first and manufacturing-centered perspective. Research and development teams benefit from a supplier capable of supporting inclusion-complex evaluation, solubility studies, analytical characterization, formulation screening, and scale-up planning. Quality professionals require traceable batch documentation and clearly defined substitution and purity criteria. Procurement teams need confidence that the material characteristics established during qualification can be maintained across repeat purchases.
When customers purchase Hydroxyethyl -Cyclodextrin for pharmaceutical or biomedical development, its safety, regulatory status, and suitability should be evaluated independently from unmodified -Cyclodextrin and other modified derivatives. Hydroxyethyl -Cyclodextrin, Hydroxypropyl -Cyclodextrin, methylated -Cyclodextrins, and Sulfobutyl ether derivatives can differ substantially in solubility, substitution pattern, biological interaction, and application suitability. They should not be treated as interchangeable without appropriate formulation and regulatory review.
The material is supported by standard technical documentation, including a Certificate of Analysis, Safety Data Sheet, and related product information where applicable. Available characterization may include identity, degree of substitution, assay or purity, water content, residual solvent information, related substances, solution characteristics, storage conditions, and retest information. Exact acceptance criteria should be confirmed for the individual grade before ordering.
Hydroxyethyl -Cyclodextrin should be handled using laboratory or manufacturing controls appropriate to the selected grade and intended application. Powder should be protected from contamination and uncontrolled moisture exposure. During solution or inclusion-complex preparation, pH, temperature, concentration, solvent composition, mixing conditions, and order of addition should be controlled because these variables can influence solubilization, complex formation, and reproducibility.
The material is packaged in appropriate containers selected to protect product quality from moisture, contamination, and environmental exposure during storage and transportation. Packaging formats, substitution options where available, minimum order quantities, availability, and lead times may be discussed according to pharmaceutical, nutraceutical, cosmetic, analytical, research, and qualified manufacturing requirements.
As with all CarboMer products, customers receive responsive technical communication and documentation support intended to advance material qualification, inclusion-complex development, formulation optimization, analytical evaluation, scale-up, and long-term supply planning.